• Je něco špatně v tomto záznamu ?

Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications

I. Ben-Aharon, HWM. van Laarhoven, E. Fontana, R. Obermannova, M. Nilsson, F. Lordick

. 2023 ; 13 (3) : 538-551. [pub] 2023Mar01

Jazyk angličtina Země Spojené státy americké

Typ dokumentu přehledy, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003928

UNLABELLED: Epidemiologic data indicate a significant increase in the incidence of colorectal cancer in younger populations in the past three decades. Moreover, recent evidence also demonstrates a similar trend in gastric, pancreatic, and biliary tract cancers. A majority of these early-onset cases are sporadic and lack hereditary or familial background, implying a potential key role for behavioral, lifestyle, nutritional, microbial, and environmental factors. This review explores the current data on early-onset gastrointestinal cancer, exploring the etiology, unique treatment considerations for this population, future challenges, as well as implications for research and practice. SIGNIFICANCE: The worrisome trend of an increasing incidence of early-onset gastrointestinal cancers appears to be correlated with nonhereditary etiologies in which behavioral, lifestyle, nutritional, microbial, and environmental factors, as well as host mechanisms, may play a key role. Further epidemiologic and pathogenetic research is urgently needed to better understand the underlying mechanisms and to develop preventive strategies and tailored early detection. Young patients with gastrointestinal cancer face unique challenges and unmet needs. These must be addressed in the future management of the disease to minimize treatment-related somatic morbidity and prevent psychosocial sequelae.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003928
003      
CZ-PrNML
005      
20230425141000.0
007      
ta
008      
230418s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/2159-8290.CD-22-1038 $2 doi
035    __
$a (PubMed)36757194
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ben-Aharon, Irit $u Division of Oncology, Rambam Health Care Center, Haifa, Israel $u Rappaport Faculty of Medicine, Technion, Haifa, Israel $u Gastrointestinal Tract Cancer Group, European Organization for Treatment and Research of Cancer (EORTC), Brussels, Belgium $1 https://orcid.org/0000000258395477
245    10
$a Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications / $c I. Ben-Aharon, HWM. van Laarhoven, E. Fontana, R. Obermannova, M. Nilsson, F. Lordick
520    9_
$a UNLABELLED: Epidemiologic data indicate a significant increase in the incidence of colorectal cancer in younger populations in the past three decades. Moreover, recent evidence also demonstrates a similar trend in gastric, pancreatic, and biliary tract cancers. A majority of these early-onset cases are sporadic and lack hereditary or familial background, implying a potential key role for behavioral, lifestyle, nutritional, microbial, and environmental factors. This review explores the current data on early-onset gastrointestinal cancer, exploring the etiology, unique treatment considerations for this population, future challenges, as well as implications for research and practice. SIGNIFICANCE: The worrisome trend of an increasing incidence of early-onset gastrointestinal cancers appears to be correlated with nonhereditary etiologies in which behavioral, lifestyle, nutritional, microbial, and environmental factors, as well as host mechanisms, may play a key role. Further epidemiologic and pathogenetic research is urgently needed to better understand the underlying mechanisms and to develop preventive strategies and tailored early detection. Young patients with gastrointestinal cancer face unique challenges and unmet needs. These must be addressed in the future management of the disease to minimize treatment-related somatic morbidity and prevent psychosocial sequelae.
650    _2
$a lidé $7 D006801
650    12
$a gastrointestinální nádory $x epidemiologie $x etiologie $7 D005770
650    _2
$a věk při počátku nemoci $7 D017668
655    _2
$a přehledy $7 D016454
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a van Laarhoven, Hanneke W M $u Gastrointestinal Tract Cancer Group, European Organization for Treatment and Research of Cancer (EORTC), Brussels, Belgium $u Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, the Netherlands $u Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands $1 https://orcid.org/0000000312745643
700    1_
$a Fontana, Elisa $u Gastrointestinal Tract Cancer Group, European Organization for Treatment and Research of Cancer (EORTC), Brussels, Belgium $u Sarah Cannon Research Institute, London, United Kingdom $1 https://orcid.org/0000000249919355
700    1_
$a Obermannova, Radka $u Gastrointestinal Tract Cancer Group, European Organization for Treatment and Research of Cancer (EORTC), Brussels, Belgium $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000173637879
700    1_
$a Nilsson, Magnus $u Gastrointestinal Tract Cancer Group, European Organization for Treatment and Research of Cancer (EORTC), Brussels, Belgium $u Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden $1 https://orcid.org/0000000262158132
700    1_
$a Lordick, Florian $u Gastrointestinal Tract Cancer Group, European Organization for Treatment and Research of Cancer (EORTC), Brussels, Belgium $u University Cancer Center Leipzig (UCCL) and 2nd Medical Department (Oncology, Gastroenterology, Hepatology, Pneumology and Infectiology), University Medicine Leipzig, Leipzig, Germany $1 https://orcid.org/0000000185919339
773    0_
$w MED00184535 $t Cancer discovery $x 2159-8290 $g Roč. 13, č. 3 (2023), s. 538-551
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36757194 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140957 $b ABA008
999    __
$a ok $b bmc $g 1924534 $s 1190137
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 3 $d 538-551 $e 2023Mar01 $i 2159-8290 $m Cancer discovery $n Cancer Discov $x MED00184535
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace